210 related articles for article (PubMed ID: 2877546)
1. Specificity of human immunodeficiency virus (LAV/HTLV-III)-reactive antibodies in African sera from southeastern Tanzania.
Schüpbach J; Tanner M
Acta Trop; 1986 Sep; 43(3):195-206. PubMed ID: 2877546
[TBL] [Abstract][Full Text] [Related]
2. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
3. [HIV (HTLV III/LAV) serology: experiences based on more than 42,000 tests].
Gschnait F; Schmidt BL; Schwarz T; Heinz FX; Kunz C
Wien Klin Wochenschr; 1987 Aug; 99(15):536-9. PubMed ID: 3310415
[TBL] [Abstract][Full Text] [Related]
4. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of two ELISA kits for the demonstration of antibodies against LAV/HTLV-III].
Heinz FX; Kunz C; Barrett N
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):196-200. PubMed ID: 3307232
[TBL] [Abstract][Full Text] [Related]
6. Enzyme immunoassays for the demonstration of antibodies to HIV-2SBL-6669 and HTLV-IV (SIVmac).
Biberfeld G; Thorstensson R; Bergström M; Naucler A; Costa CM
AIDS; 1988 Jun; 2(3):195-9. PubMed ID: 3134913
[TBL] [Abstract][Full Text] [Related]
7. [Serology in HIV infection: comparison of indirect immunofluorescence, Western blot and enzyme immunoassay].
Schmidt BL; Hutterer J; Kunz C; Gschnait F
Wien Med Wochenschr; 1988 Apr; 138(8):174-80. PubMed ID: 3043921
[TBL] [Abstract][Full Text] [Related]
8. Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.
Lange JM; de Wolf F; Krone WJ; Danner SA; Coutinho RA; Goudsmit J
AIDS; 1987 Sep; 1(3):155-9. PubMed ID: 3126756
[TBL] [Abstract][Full Text] [Related]
9. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China.
Zeng Y; Fan J; Zhang Q; Wang PC; Tang DJ; Zhon SC; Zheng XW; Liu DP
AIDS Res; 1986 Dec; 2 Suppl 1():S147-9. PubMed ID: 3103638
[TBL] [Abstract][Full Text] [Related]
10. Extrathecal and intrathecal IgG response to the AIDS virus LAV/HTLV-III in experimental infection of chimpanzees.
Goudsmit J; Gibbs CJ; Asher DM; Gajdusek DC
Cancer Detect Prev Suppl; 1987; 1():509-14. PubMed ID: 3480064
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of HTLV-III/LAV antibody in selected populations in Thailand.
Wangroongsarb Y; Weniger BG; Wasi C; Traisupa A; Kunasol P; Rojanapithayakorn W; Fucharoen S
Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):517-20. PubMed ID: 3869739
[TBL] [Abstract][Full Text] [Related]
12. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)].
Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G
Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290
[No Abstract] [Full Text] [Related]
13. HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis.
Madden DL; Tzan NR; Roman GC; Detels R; Mundon FK; Fuccillo DA; Sever JL
Yale J Biol Med; 1987; 60(6):569-74. PubMed ID: 2893497
[TBL] [Abstract][Full Text] [Related]
14. Detection of anti-HIV-1 IgG antibodies in whole saliva by GACELISA and Western blot assays.
Matee MI; Lyamuya EF; Simon E; Mbena EC; Kagoma C; Samaranayake LP; Scheutz F
East Afr Med J; 1996 May; 73(5):292-4. PubMed ID: 8756029
[TBL] [Abstract][Full Text] [Related]
15. Serologic characterization of human immunodeficiency virus infection by Western blot and radioimmunoprecipitation assays.
Resnick L; Shapshak P
Arch Pathol Lab Med; 1987 Nov; 111(11):1040-4. PubMed ID: 3478005
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan.
Ikegami N
AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J
Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208
[TBL] [Abstract][Full Text] [Related]
18. [Detection of antibodies to HTLV-III: a comparison of various ELISA methods as screening tests and the Western Blot with immunofluorescence as confirmatory procedures].
Hengster P; Larcher C; Pöckl E; Schulz T; Wachter H; Dierich MP
Wien Klin Wochenschr; 1987 Feb; 99(4):112-4. PubMed ID: 3554776
[TBL] [Abstract][Full Text] [Related]
19. Reliable screening anti HIV with a new ultrasensitive ELISA procedure.
Krupka U
Behring Inst Mitt; 1988 Apr; (82):325-37. PubMed ID: 3165635
[TBL] [Abstract][Full Text] [Related]
20. Lack of cross-reaction in antibody-dependent cellular cytotoxicity between human immunodeficiency virus (HIV) and HIV-related West African strains.
Ljunggren K; Chiodi F; Biberfeld G; Norrby E; Jondal M; Fenyö EM
J Immunol; 1988 Jan; 140(2):602-5. PubMed ID: 3335784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
